TURNSTONE BIOLOGICS CORP (TSBX)
Institutional ownership reported to the SEC as of Q2 2025, across 8 quarters.
21
Reporting holders
$3.0M
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $1.1M | 3,099,265 | 0.03% | 8q | HELD |
| FMR LLC | $407.1K | 1,133,987 | 0.00% | 8q | HELD |
| BML Capital Management, LLC | $396.1K | 1,103,386 | 0.30% | 2q | HELD |
| TAKEDA PHARMACEUTICAL CO LTD | $321.6K | 895,824 | 1.64% | 7q | HELD |
| Point72 Asset Management, L.P. | $293.3K | 816,923 | 0.00% | 8q | -7.1%-$22.3K |
| 72 Investment Holdings, LLC | $197.4K | 549,980 | 0.52% | 8q | HELD |
| CITADEL ADVISORS LLC | $75.0K | 208,887 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $46.7K | 130,077 | 0.00% | 8q | -4.9%-$2.4K |
| DELTEC ASSET MANAGEMENT LLC | $38.1K | 106,057 | 0.01% | new | NEW |
| VANGUARD GROUP INC | $30.1K | 83,926 | 0.00% | 8q | -83.7%-$154.8K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $28.5K | 79,305 | 0.00% | 3q | +213.4%+$19.4K |
| RENAISSANCE TECHNOLOGIES LLC | $16.9K | 47,100 | 0.00% | 3q | +17.2%+$2.5K |
| GTS SECURITIES LLC | $16.2K | 45,163 | 0.00% | new | NEW |
| XTX Topco Ltd | $13.6K | 37,786 | 0.00% | 3q | +5.7% |
| NORTHERN TRUST CORP | $6.6K | 18,405 | 0.00% | 8q | HELD |
| Tower Research Capital LLC (TRC) | $1.7K | 4,741 | 0.00% | 8q | HELD |
| BlackRock, Inc. | $383 | 1,066 | 0.00% | 4q | -97.5%-$14.9K |
| JPMORGAN CHASE & CO | $57 | 158 | 0.00% | 8q | -19.4% |
| BANK OF AMERICA CORP /DE/ | $54 | 150 | 0.00% | 8q | -100.0%-$320.9K |
| BNP PARIBAS FINANCIAL MARKETS | $43 | 121 | 0.00% | 3q | HELD |
| UBS Group AG | $25 | 71 | 0.00% | 8q | HELD |
| HRT FINANCIAL LP | $20 | 55,859 | 0.00% | 2q | +362.3% |
| ACADIAN ASSET MANAGEMENT LLC | $4 | 16,430 | 0.00% | 4q | -7.9% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 21 | $3.0M | 8,362,378 | 3 | 3 | 6 | 0.0% |
| Q1 2025 | 21 | $4.2M | 10,363,179 | 2 | 2 | 10 | 0.0% |
| Q4 2024 | 26 | $5.5M | 11,063,850 | 6 | 4 | 6 | 0.0% |
| Q3 2024 | 22 | $6.1M | 10,952,724 | 0 | 4 | 9 | 0.0% |
| Q2 2024 | 43 | $32.0M | 12,229,898 | 13 | 10 | 11 | 0.0% |
| Q1 2024 | 37 | $34.1M | 13,032,806 | 4 | 18 | 6 | 0.0% |
| Q4 2023 | 34 | $32.5M | 12,772,352 | 2 | 13 | 7 | 0.0% |
| Q3 2023 | 33 | $46.8M | 11,882,398 | 33 | 0 | 0 | 0.0% |